Incidence, Serogroups and Case-Fatality Rate of Invasive Meningococcal Infections in a Swedish Region 1975–1989
- 1 January 1992
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 24 (3) , 333-338
- https://doi.org/10.3109/00365549209061339
Abstract
In a retrospective study of invasive meningococcal infections in Greater Gothenburg, Sweden, 213 cases of culture-verified meningitis or septicaemia were identified during the 15-year period 1975–1989. The annual incidence was 2.0/100000. Cases were seen in all age-groups with the highest rates in the 0–4 and 15–19 year-old groups, 9.5 and 6.2/100000 respectively. 20% of the patients were < 2 years. 91% of the patients had no known risk factors. In only 10 cases (5%) was contact with another case of meningococcal infection known. The main clinical manifestations were meningitis (57%), septicaemia with no sign of focal infection (25%) and septic shock (17%). The case-fatality rate for all the patients was 6.6% and did not change during the 15-year period. One-third of the patients who presented with septic shock died. The serogroup was known for strains from 192 patients. 51% of the strains belonged to serogroup B, 10% to group A and 23% to group C. In conclusion, the incidence of meningococcal infection was low but the relatively high case-fatality rate warrants a search for effective prophylaxis. About 30% of the cases were potentially preventable by the currently available tetravalent (A, C, Y and W135) polysaccharide vaccine, which is immunogenic in children > 2 years. Widespread use of antibiotic prophylaxis to close contacts of known cases would not lower the incidence markedly.Keywords
This publication has 16 references indexed in Scilit:
- Immunogenicity in adult males of a Neisseria meningitidis group B vaccine composed of polysaccharide complexed with outer membrane proteinsVaccine, 1991
- Meningococcal meningitis.BMJ, 1990
- Another Swedish Family with Complete Properdin Deficiency: Association with Fulminant Meningococcal Disease in one Male Family MemberScandinavian Journal of Infectious Diseases, 1989
- Complement Deficiencies in Selected Groups of Patients with Meningococcal DiseaseScandinavian Journal of Infectious Diseases, 1989
- An outbreak of meningococcal disease in Auckland, New ZealandThe Pediatric Infectious Disease Journal, 1989
- Increased Incidence of Childhood Bacterial Meningitis: A 25-Year Study in a Defined Population in SwedenScandinavian Journal of Infectious Diseases, 1987
- PREVALENCE OF COMPLEMENT DEFICIENCIES IN CHILDREN WITH SYSTEMIC MENINGOCOCCAL INFECTIONSThe Pediatric Infectious Disease Journal, 1987
- AGE-SPECIFIC DIFFERENCES IN DURATION OF CLINICAL PROTECTION AFTER VACCINATION WITH MENINGOCOCCAL POLYSACCHARIDE A VACCINEThe Lancet, 1985
- Meningococcal a and Other Polysaccharide VaccinesNew England Journal of Medicine, 1983
- Is there a genetic immune defect in families with meningococcal meningitis?Journal of Infection, 1981